Chronic Nicotine Exposure Alters the Neurophysiology of Habenulo-Interpeduncular Circuitry. 2019

Matthew C Arvin, and Xiao-Tao Jin, and Yijin Yan, and Yong Wang, and Matthew D Ramsey, and Veronica J Kim, and Nicole A Beckley, and Brittany A Henry, and Ryan M Drenan
Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611.

Antagonism of nicotinic acetylcholine receptors (nAChRs) in the medial habenula (MHb) or interpeduncular nucleus (IPN) triggers withdrawal-like behaviors in mice chronically exposed to nicotine, implying that nicotine dependence involves the sensitization of nicotinic signaling. Identification of receptor and/or neurophysiological mechanisms underlying this sensitization is important, as it could promote novel therapeutic strategies to reduce tobacco use. Using an approach involving photoactivatable nicotine, we previously demonstrated that chronic nicotine (cNIC) potently enhances nAChR function in dendrites of MHb neurons. However, whether cNIC modulates downstream components of the habenulo-interpeduncular (Hb-IP) circuit is unknown. In this study, cNIC-mediated changes to Hb-IP nAChR function were examined in mouse (male and female) brain slices using molecular, electrophysiological, and optical techniques. cNIC enhanced action potential firing and modified spike waveform characteristics in MHb neurons. Nicotine uncaging revealed nAChR functional enhancement by cNIC on proximal axonal membranes. Similarly, nAChR-driven glutamate release from MHb axons was enhanced by cNIC. In IPN, the target structure of MHb axons, neuronal morphology, and nAChR expression is complex, with stronger nAChR function in the rostral subnucleus [rostral IPN (IPR)]. As in MHb, cNIC induced strong upregulation of nAChR function in IPN neurons. This, coupled with cNIC-enhanced nicotine-stimulated glutamate release, was associated with stronger depolarization responses to brief (1 ms) nicotine uncaging adjacent to IPR neurons. Together, these results indicate that chronic exposure to nicotine dramatically alters nicotinic cholinergic signaling and cell excitability in Hb-IP circuits, a key pathway involved in nicotine dependence.SIGNIFICANCE STATEMENT This study uncovers several neuropharmacological alterations following chronic exposure to nicotine in a key brain circuit involved in nicotine dependence. These results suggest that smokers or regular users of electronic nicotine delivery systems (i.e., "e-cigarettes") likely undergo sensitization of cholinergic circuitry in the Hb-IP system. Reducing the activity of Hb-IP nAChRs, either volitionally during smoking cessation or inadvertently via receptor desensitization during nicotine intake, may be a key trigger of withdrawal in nicotine dependence. Escalation of nicotine intake in smokers, or tolerance, may involve stimulation of these sensitized cholinergic pathways. Smoking cessation therapeutics are only marginally effective, and by identifying cellular/receptor mechanisms of nicotine dependence, our results take a step toward improved therapeutic approaches for this disorder.

UI MeSH Term Description Entries
D008297 Male Males
D009434 Neural Pathways Neural tracts connecting one part of the nervous system with another. Neural Interconnections,Interconnection, Neural,Interconnections, Neural,Neural Interconnection,Neural Pathway,Pathway, Neural,Pathways, Neural
D009435 Synaptic Transmission The communication from a NEURON to a target (neuron, muscle, or secretory cell) across a SYNAPSE. In chemical synaptic transmission, the presynaptic neuron releases a NEUROTRANSMITTER that diffuses across the synaptic cleft and binds to specific synaptic receptors, activating them. The activated receptors modulate specific ion channels and/or second-messenger systems in the postsynaptic cell. In electrical synaptic transmission, electrical signals are communicated as an ionic current flow across ELECTRICAL SYNAPSES. Neural Transmission,Neurotransmission,Transmission, Neural,Transmission, Synaptic
D009538 Nicotine Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke. Nicotine Bitartrate,Nicotine Tartrate
D011978 Receptors, Nicotinic One of the two major classes of cholinergic receptors. Nicotinic receptors were originally distinguished by their preference for NICOTINE over MUSCARINE. They are generally divided into muscle-type and neuronal-type (previously ganglionic) based on pharmacology, and subunit composition of the receptors. Nicotinic Acetylcholine Receptors,Nicotinic Receptors,Nicotinic Acetylcholine Receptor,Nicotinic Receptor,Acetylcholine Receptor, Nicotinic,Acetylcholine Receptors, Nicotinic,Receptor, Nicotinic,Receptor, Nicotinic Acetylcholine,Receptors, Nicotinic Acetylcholine
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014029 Tobacco Use Disorder Tobacco used to the detriment of a person's health or social functioning. Tobacco dependence is included. Nicotine Addiction,Nicotine Dependence,Nicotine Use Disorder,Tobacco Dependence,Tobacco-Use Disorder,Addiction, Nicotine,Dependence, Nicotine,Dependence, Tobacco,Disorder, Nicotine Use,Disorder, Tobacco Use,Disorder, Tobacco-Use,Nicotine Addictions,Nicotine Use Disorders,Tobacco Use Disorders
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D018722 Nicotinic Agonists Drugs that bind to and activate nicotinic cholinergic receptors (RECEPTORS, NICOTINIC). Nicotinic agonists act at postganglionic nicotinic receptors, at neuroeffector junctions in the peripheral nervous system, and at nicotinic receptors in the central nervous system. Agents that function as neuromuscular depolarizing blocking agents are included here because they activate nicotinic receptors, although they are used clinically to block nicotinic transmission. Cholinergic Agonists, Nicotinic,Cholinergic Agonist, Nicotinic,Nicotinic Agonist,Agonist, Nicotinic,Agonist, Nicotinic Cholinergic,Agonists, Nicotinic,Agonists, Nicotinic Cholinergic,Nicotinic Cholinergic Agonist,Nicotinic Cholinergic Agonists

Related Publications

Matthew C Arvin, and Xiao-Tao Jin, and Yijin Yan, and Yong Wang, and Matthew D Ramsey, and Veronica J Kim, and Nicole A Beckley, and Brittany A Henry, and Ryan M Drenan
September 2015, Neuropharmacology,
Matthew C Arvin, and Xiao-Tao Jin, and Yijin Yan, and Yong Wang, and Matthew D Ramsey, and Veronica J Kim, and Nicole A Beckley, and Brittany A Henry, and Ryan M Drenan
June 2013, Cold Spring Harbor perspectives in medicine,
Matthew C Arvin, and Xiao-Tao Jin, and Yijin Yan, and Yong Wang, and Matthew D Ramsey, and Veronica J Kim, and Nicole A Beckley, and Brittany A Henry, and Ryan M Drenan
February 2017, Trends in pharmacological sciences,
Matthew C Arvin, and Xiao-Tao Jin, and Yijin Yan, and Yong Wang, and Matthew D Ramsey, and Veronica J Kim, and Nicole A Beckley, and Brittany A Henry, and Ryan M Drenan
June 2005, Neurotoxicology,
Matthew C Arvin, and Xiao-Tao Jin, and Yijin Yan, and Yong Wang, and Matthew D Ramsey, and Veronica J Kim, and Nicole A Beckley, and Brittany A Henry, and Ryan M Drenan
January 2020, Scientific reports,
Matthew C Arvin, and Xiao-Tao Jin, and Yijin Yan, and Yong Wang, and Matthew D Ramsey, and Veronica J Kim, and Nicole A Beckley, and Brittany A Henry, and Ryan M Drenan
March 2009, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Matthew C Arvin, and Xiao-Tao Jin, and Yijin Yan, and Yong Wang, and Matthew D Ramsey, and Veronica J Kim, and Nicole A Beckley, and Brittany A Henry, and Ryan M Drenan
December 1977, Experimental neurology,
Matthew C Arvin, and Xiao-Tao Jin, and Yijin Yan, and Yong Wang, and Matthew D Ramsey, and Veronica J Kim, and Nicole A Beckley, and Brittany A Henry, and Ryan M Drenan
December 1983, Neuroscience letters,
Matthew C Arvin, and Xiao-Tao Jin, and Yijin Yan, and Yong Wang, and Matthew D Ramsey, and Veronica J Kim, and Nicole A Beckley, and Brittany A Henry, and Ryan M Drenan
October 1973, Experimental neurology,
Matthew C Arvin, and Xiao-Tao Jin, and Yijin Yan, and Yong Wang, and Matthew D Ramsey, and Veronica J Kim, and Nicole A Beckley, and Brittany A Henry, and Ryan M Drenan
June 2016, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Copied contents to your clipboard!